European Paediatric and Amblyopia Treatment study for Children (EuPATCH): the role of feedback on adherence to amblyopia treatment

The effect of feedback to adherence to glasses and patch wear in amblyopia treatment: a randomised clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN85110914

Enrollment

102

Registered

2013-08-23

Start date

2013-10-01

Completion date

Unknown

Last updated

2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amblyopia Eye Diseases Amblyopia

Interventions

There will be two treatment arms: A. Feedback Group: A period of 12 weeks of full-time glasses wearing and patching (10 hrs/day, 6 days/week) followed by feedback on hours of glasses a

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Children (age range is between 2-8 years inclusive) with monocular amblyopia (difference of = 0.3 logMAR visual acuity between eyes) due to anisometropia (= 1.5D in at least one eye or 1D difference between the two eyes), strabismus or both 2. Previous patching = 18 months

Exclusion criteria

Exclusion criteria: Children with other ophthalmic or neurological diseases, bilateral amblyopia or premature children.

Design outcomes

Primary

Measure	Time frame
Adherence is determined as the the number of hours patched patching over 12 weeks.	—

Secondary

Measure	Time frame
1. Number of hours of glasses wear over the 12 week period. 2. Visual outcome using the formula described by Stewart et al. (% deficit corrected) over the 12 week period	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026